Impact of FDA endorsement and modified risk versus exposure messaging in IQOS ads: a randomised factorial experiment among US and Israeli adults.

Carla J Berg Zongshuan DuanYan WangJames F ThrasherYael Bar Zeev Lorien C Abroms Katelyn F Romm Amal KhayatHagai Levine

Published in: Tobacco control (2022)

Regulators must monitor direct and indirect advertising content of modified risk tobacco product-authorised products and prevent potentially harmful misinterpretations.

Keyphrases

clinical trial
open label
randomized controlled trial
study protocol
smoking cessation
double blind